The daily burden for those living with type 1 diabetes is constant, and Breakthrough T1D remains focused on accelerating the path to cures for the disease,” said Nicholas Mamrak, Ph.D., scientist at ...
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of new research in Science Advances detailing the company’s CRISPR-based ...
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, has published new research in ...
Many Python fans have longed for the language to adopt functional programming features. Now they can get those features without having to switch to a new Python implementation. Coconut, a newly ...